Company
L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
AROMICS is a development-stage biotechnology company focused on development of novel therapies and molecular diagnostic methods for the management and treatment of cancer and infectious diseases.
Barcelona, Catalonia, Spain
Send a message
Anglais
Anglais
AROMICS is a development-stage biotech company based in Barcelona and focused on development of novel therapies for the treatment of important human disease like cancer. Over last years the company has been focused on the development of small molecules targeting RNA. A first lead is advancing into clinical trials in a first indication, malignant mesothelioma, a rare and incurable disease linked to asbestos exposure.
1
Followers
Start in 02/09/2005
02/09/2005
Four entrerprenours created AROMICS to try to integrate OMIC sciences in drug development process.
2011-2013
Join agreement with Acceleration Biopharmaceuticals for AB200 development for viral coinfection
2012-2015
R&D collaboration agreement with Naxospharma srl for the development of novel NAX anticancer agents
2016
European Patent granted and entrance on Spanish country of NAX35 anticancer agent. License agreement
2017-2021
Completed manufacture API and regulatory preclinical package 400KE investment+ 1.55Mn E (EU grant)
to be continued ...